Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

ChemRx and DuPont sign chemistry collaboration

June 15, 1999

No Comments

Selective Genetics and Biomet form alliance for orthopedic therapy

June 11, 1999

No Comments

Two U.S. patents licensed to Aastrom broaden coverage for cell therapy technologies

June 8, 1999

No Comments

Roche and Sangamo sign Universal GeneTools research agreement

June 8, 1999

No Comments

GenVec obtains rights to patents covering HSV vectors for gene therapy in nervous system disorders

June 7, 1999

No Comments

Dimethaid commences new topical antifungal study

June 4, 1999

No Comments

Structural Bioinformatics and DuPont announce strategic alliance

June 3, 1999

No Comments

DGI BioTechnologies and Novo Nordisk sign collaboration

June 3, 1999

No Comments

Ontogeny and Oxford Asymmetry announce lead optimization collaboration

May 31, 1999

No Comments

Maxygen receives milestone payment from Pfizer

May 28, 1999

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

ChemRx and DuPont sign chemistry collaboration

Selective Genetics and Biomet form alliance for orthopedic therapy

Two U.S. patents licensed to Aastrom broaden coverage for cell therapy technologies

Roche and Sangamo sign Universal GeneTools research agreement

GenVec obtains rights to patents covering HSV vectors for gene therapy in nervous system disorders

Dimethaid commences new topical antifungal study

Structural Bioinformatics and DuPont announce strategic alliance

DGI BioTechnologies and Novo Nordisk sign collaboration

Ontogeny and Oxford Asymmetry announce lead optimization collaboration

Maxygen receives milestone payment from Pfizer

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS